The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma

類似資料

• MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR‐induced NF‐κB activation
  著者:: Liu, Xuejiao, 等
  出版事項: (2020)
• Overcoming acquired resistance to AZD9291, a third generation EGFR inhibitor, through modulation of MEK/ERK-dependent Bim and Mcl-1 degradation
  著者:: Shi, Puyu, 等
  出版事項: (2017)
• Inhibition of chromosomal region maintenance 1 suppresses the migration and invasion of glioma cells via inactivation of the STAT3/MMP2 signaling pathway
  著者:: Shan, Qianqian, 等
  出版事項: (2020)
• AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer
  著者:: Cross, Darren A. E., 等
  出版事項: (2014)
• Synergistic effects of Bcl-2 inhibitors with AZD9291 on overcoming the acquired resistance of AZD9291 in H1975 cells
  著者:: Liu, Zhongwei, 等
  出版事項: (2020)